PhD Scientific Days 2025

Budapest, 7-9 July 2025

Poster Session I. - D: Pathological and Oncological Sciences

Resolving Complex Rearrangements and Improving Variant Analysis in Pediatric B-ALL Using Optical Genome Mapping

Name of the presenter

Bekő Anna

Institute/workplace of the presenter

Department of Pathology and Experimental Cancer Research, Semmelweis University

Authors

Anna Bekő1, Borbála Péterffy1, Alex Hughes1, Janka Jakab1, Katalin Csonka1, Gergő Papp1, Dóra Kapczár1, Bettina Aranka Bohusné Barta1, Bálint Egyed2, Irén Haltrich2, Lajos Hegyi1, Anne Benard-Slagter3, Suvi Savola3, Donát Alpár1, Csaba Bödör1

1: Department of Pathology and Experimental Cancer Research, Semmelweis University
2: Pediatric Center, Semmelweis University
3: MRC Holland, Amsterdam, the Netherlands

Text of the abstract

Introduction: Detection of structural variants (SVs) and copy number variations (CNVs) is crucial in pediatric B-cell acute lymphoblastic leukemia (p-B-ALL) diagnostics. However, limitations of FISH and chromosome banding analysis (CBA) may challenge the accurate cytogenetic characterization, while optical genome mapping (OGM) offers a reliable solution by enabling genome-wide detection of CNVs and SVs.
Aims: To detect chromosomal aberrations in p-B-ALL using OGM and to test its feasibility for clinical diagnostics compared to CBA, FISH, targeted RNA sequencing (RNA-seq), and digitalMLPA. Additionally, to develop a more precise variant interpretation.
Method: CBA, FISH, targeted RNA-seq (TruSight RNA Pan-Cancer Panel, Illumina), and OGM (Bionano Genomics) were performed on diagnostic bone marrow samples from 51 p-B-ALL patients at Semmelweis University. digitalMLPA was conducted at MRC Holland. OGM variant analysis was performed in Bionano Access v1.8.1. Statistical analyses were performed in SPSS v.28.0.1.
Results: CBA detected aberrations in 13/51 patients; OGM fully confirmed the findings in 10 cases. OGM detected high hyperdiploidy in 5 cases with normal karyotypes and generated digital karyotypes for all 21 CBA-failed cases. OGM data and results of the FISH probes were congruent in 91%. In 93% of CNV discordancies, digitalMLPA confirmed OGM findings. OGM detected 156 translocations, 40% (n=62) overlapping with RNA-seq panel genes (38 validated, 24 unvalidated). Among the unvalidated fusions, in 11 variants, ETV6 or RUNX1 genes were involved in complex ETV6::RUNX1 fusions (8/11 validated by FISH). CNVs identified by OGM and digitalMLPA showed almost perfect overall agreement (Cohen’s Kappa (CK)=0.93). For the 153 genes associated with ALL, agreement between CNV values was perfect (CK=1) in 76%. In the regions on the variants’ periphery in the OGM analysis, in grey-zones, by applying a novel evaluation strategy, the concordant CNV values significantly increased. After re-evaluating grey-zone areas, CK interpretation level was updated in 10/11 genes.
Conclusion: Application of OGM revealed complex rearrangements challenging to detect by other methods and led to improved classification of the patients. Notably, our newly introduced evaluation approach also offers a novel, more accurate OGM variant analysis.
Funding: SE250+ grant, KDP-2023-00016